Submission Meeting Dates / Timelines

Castle IRB meets once a week (Wednesdays) for convened Board Meetings. Ad hoc meetings can be scheduled as needed with the IRB team. Please see submission deadline information below.

Expedited Reviews have no submission deadlines and are reviewed upon receipt.

Full Board Review

Submissions must be received the Monday before the following week’s Wednesday Board Meeting.
Turnaround time: [10 business days or less from study submission to IRB review and Determination Letter distribution]

Expedited Review (if applicable)

No submission deadlines
Main study review turnaround time: [typically 5 business days or less from study submission to IRB review and Determination Letter distribution]
PI/site (multi-investigator projects): [2-3 days from PI/site submission following main study review]

Ongoing submissions following Initial Review

If requires Full Board: turnaround time and submission deadline as noted above
If can be reviewed via Expedited Review: turnaround time as noted above

Mission Statement

The mission of Castle IRB is to protect the rights and welfare of human participants in gene and cell therapy clinical trials while providing efficient, compliant IRB review of research. Using our portfolio of expertise, we strive to be the leading IRB partner in advancing safe, ethical and compliant gene and cell therapy clinical trials to accelerate the next evolution in advanced therapies.

Sabai Family

Sabai Global

Clinical Biosafety Services

Castle IRB

Shield Consulting